These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32469890)

  • 41. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Okute Y; Shoji T; Hayashi T; Kuwamura Y; Sonoda M; Mori K; Shioi A; Tsujimoto Y; Tabata T; Emoto M; Inaba M
    J Atheroscler Thromb; 2017 Apr; 24(4):412-421. PubMed ID: 27629255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis.
    Ishii J; Nomura M; Okuma T; Minagawa T; Naruse H; Mori Y; Ishikawa T; Kurokawa H; Hirano T; Kondo T; Nagamura Y; Ezaki K; Hishida H
    Clin Chim Acta; 2001 Oct; 312(1-2):69-79. PubMed ID: 11580911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased plasma level of catestatin might be associated with poor prognosis in hemodialysis patients.
    Sun H; Xian W; Geng L; Li E; Peng Z; Tian J
    Int Urol Nephrol; 2017 Jun; 49(6):1063-1069. PubMed ID: 28161844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mathematical model to predict B-type natriuretic peptide levels in haemodialysis patients.
    Touzot M; Seris P; Maheas C; Vanmassenhove J; Langlois AL; Moubakir K; Laplanche S; Petitclerc T; Ridel C; Lavielle M
    Nephrology (Carlton); 2020 Jan; 25(1):82-89. PubMed ID: 30887608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis.
    Ishizaka Y; Yamamoto Y; Fukunaga T; Yokota N; Kida O; Kitamura K; Kangawa K; Minamino N; Matsuo H; Eto T
    Am J Kidney Dis; 1994 Sep; 24(3):461-72. PubMed ID: 8079971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble (pro)renin receptor in preeclampsia and diabetic pregnancies.
    Sugulle M; Heidecke H; Maschke U; Herse F; Danser AHJ; Mueller DN; Staff AC; Dechend R
    J Am Soc Hypertens; 2017 Oct; 11(10):644-652. PubMed ID: 29050747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of maintenance hemodialysis with hemoperfusion: a safe and effective model of artificial kidney.
    Chen SJ; Jiang GR; Shan JP; Lu W; Huang HD; Ji G; Wu P; Wu GF; Wang W; Zhu C; Bian F
    Int J Artif Organs; 2011 Apr; 34(4):339-47. PubMed ID: 21534244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patients.
    Westenbrink BD; Hovinga TK; Kloppenburg WD; Veeger NJ; Janssen WM
    Clin Nephrol; 2011 Nov; 76(5):373-9. PubMed ID: 22000557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
    Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
    Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F
    J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
    Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
    Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain natriuretic peptide reflects individual variation in hydration status in hemodialysis patients.
    Stenberg J; Melin J; Lindberg M; Furuland H
    Hemodial Int; 2019 Jul; 23(3):402-413. PubMed ID: 30848066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular endothelial growth factor D is a biomarker of fluid overload in haemodialysis patients.
    von Moos S; Segerer S; Davenport A; Sadoune M; Gerritsen K; Pottecher J; Ruschitzka F; Mebazaa A; Arrigo M; Cippà PE
    Nephrol Dial Transplant; 2021 Feb; 36(3):529-536. PubMed ID: 31923307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac biomarkers are influenced by dialysis characteristics.
    Sommerer C; Heckele S; Schwenger V; Katus HA; Giannitsis E; Zeier M
    Clin Nephrol; 2007 Dec; 68(6):392-400. PubMed ID: 18184522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons.
    Ueda R; Yokouchi M; Suzuki T; Otomo E; Katagiri T
    Am J Med; 2003 Mar; 114(4):266-70. PubMed ID: 12681452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Olmesartan medoxomil treatment is associated with decreased plasma B-type natriuretic peptide levels in patients on hemodialysis.
    Suzuki R; Honda H; Niikura K; Akizawa T
    Clin Exp Hypertens; 2012; 34(2):125-31. PubMed ID: 21967019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function.
    Collado S; Coll E; Nicolau C; Azqueta M; Pons M; Cruzado JM; de la Torre B; Deulofeu R; Mojal S; Pascual J; Cases A
    BMC Nephrol; 2017 Sep; 18(1):290. PubMed ID: 28882110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum levels of N-terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis.
    Zoair AM; Abdel-Hafez MA; Mawlana W; Sweylam MA
    Saudi J Kidney Dis Transpl; 2016; 27(6):1114-1122. PubMed ID: 27900955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
    Desideri G; Panichi V; Paoletti S; Grassi D; Bigazzi R; Beati S; Bernabini G; Rosati A; Ferri C; Taddei S; Ghiadoni L;
    Nephrol Dial Transplant; 2011 Sep; 26(9):2983-8. PubMed ID: 21303961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.